Ruth Neale
Programme Manager
Jasmin Major
04 Mar 2022
This World Engineering Day, we want to celebrate and highlight engineering achievements and improve public understanding of how engineering and technology are central to modern life, health and for sustainable development across the globe.
Covid-19 has highlighted the value of diagnostic technologies to global healthcare and society. For many years, innovators have been developing and refining the next generation of rapid antimicrobial resistance (AMR) diagnostic tests. The Global Research on Antimicrobial Resistance (GRAM) study in the Lancet revealed that AMR has become a leading cause of death worldwide, with more than 1.2 million people dying as a direct result of antibiotic drug-resistant bacterial infections in 2019. At the end of 2021, The Lancet Commission on Diagnostics found that a staggering 47% of the global population have little to no access to diagnostics.
There is both a need to increase access to appropriately-designed diagnostics developed in high-income countries (HICs) for low-and middle-income countries (LMICs) and to locally develop more products in and for LMICs. To achieve commercial success and build a sustainable business, most diagnostic developers focus on tests that suit HICs, although not an issue unique to novel AMR diagnostics.
AMR& Diagnostic Frontiers brought diagnostic developers together with global health experts to discuss the manufacturing adaptation of and development of homegrown AMR diagnostics. The event included successful diagnostic stories developed locally in Morocco, India and Senegal. Please see the full list of speakers and panelists below.
Also on this topic, check out the Longitude Prize guide How to make AMR diagnostics globally applicable in LMIC settings for diagnostic developers.
Welcome and Keynote [video 01:05]
Chair: Bill Rodriguez, CEO, FIND
Dr. Patty Garcia, Professor, Universidad Peruana Cayetano Heredia, Peru (UPCH) and Commissioner, Lancet Commission on Diagnostics shared key highlights and recommendations from the Lancet Commission published in October 2021.
Diagnostic Success Models and Stories from Morocco, India and Senegal [video 20:30]
Diagnostic developers shared successful models and stories of the development, adaptation and rollout of diagnostics in an LMIC setting – and their perspectives on how, looking ahead, LMICs can build homegrown innovation capacity to deliver accessible, rapid diagnostics.
Speakers:
Technology Pipeline: product feedback and market outlook with global health panel [video 54:30]
Companies developing AMR diagnostics for an LMIC setting presented their products to a panel of global health representatives who shared customer-driven feedback on their technology, access and pathway to market.
Chair: Erin Duffy, Chief of Research and Development, CARB-X
Presentees:
Panel:
Closing Remarks [video 1:58:00]
Erin Duffy, CARB-X
Blog
Event
Congratulations to the winners of the Longitude Prize on AMR, Sysmex Astrego!